Calcium-based antacid chews are estimated at 41.4% of product type spending in 2026 while first trimester represents 45.7% and chews & drops account for 46.2%. Portable acid-relief formats fit pregnancy routines, but repeat purchase depends on clear dosing, interaction guidance and ingredient disclosure.